Would you like to be more informed about the range of potential treatment options for your health problem? Would you consider a clinical trial? If you are considering participating in a clinical trial, please check the resources for understanding clinical trials.
A clinical trial is a research study that evaluates the effectiveness and safety of new medications or medical devices to help with your health problem. Clinical trials may be the way for you to receive promising new therapies that are not available otherwise.
To view studies taking place at the University of Pittsburgh, please visit Pitt+Me to search by research study area.
Please check the extensive U.S. National Institutes of Health Clinical Trials database. This service is provided by the United States National Institutes of Health. The site provides free access to information on clinical studies for a wide range of diseases and conditions. Clinical trials from all over the world are included in this database.
The UPMC Vision Institute has numerous open trials. Please check our list below.
UPMC Vision Institute Currently Enrolling Clinical Trials
If you are interested in any of our currently enrolling clinical trials, please call our triage number: 412-642-7888
- Retina Studies
-
Condition Study Nickname Title of Study Study Coordinator Uveitis ACELYRIN A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Non-infectious, Intermediate-, Posterior- or Pan-uveitis Rhonda Dahlstrom: dahlstromrj@upmc.edu AMD, nAMD, wAMD, CNV ASCENT A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants with nAMD Sashan Morris: morriss10@upmc.edu Geographic Atrophy OCUGEN A Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographyic Atrophy Secondary to Dry Age-Related Macular Degeneration Sashan Morris: morriss10@upmc.edu Inherited Retinal Diseases NOPROD Global Patient Registry of Inherited Retinal Diseases Natalie Anthony: anthonynl2@upmc.edu Retinitis Pigmentosa PRODYGY A Phase I/II Study to Assess the Safety and Tolerability of a Single Subretinal Administration of SPVN06 Gene Therapy in Subjects with Rod-Cone Dystrophy (RCD) Due to a Mutation in the RHO, PDE6A, or PDE6B Gene Natalie Anthony: anthonynl2@upmc.edu Inherited Retinal Degeneration, Retinitis Pigmentosa UNI-RARE Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated with Rare Disease-Causing Genetic Variants Chad Indermill: indermillc@upmc.edu X-Linked Retinitis Pigmentosa VISTA A Randomized, Controlled, Masked, Multi-center Study Evaluating the Efficacy, Safety, and Tolerability of Two Doses of AGTC-501 Compared to an Untreated Control Group in Male Participants with X-linked Retinitis Pigmentosa Dipanwita Samanta: samantad@upmc.edu - Cornea Studies
-
Condition Study Nickname Title of Study Study Coordinator Persistent Corneal Epithelial Defect CHASE A Study to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants with Persistent Corneal Epithelial Defect (PCED) Alec Bertoni: bertoniar@upmc.edu Keratoconus CXL A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus (APRICITY-A) Alec Bertoni: bertoniar@upmc.edu Neurotrophic Keratopathy SEER-2 A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy (SEER-2) Chad Indermill: indermillc@upmc.edu Hyperopia TENEO A Study to Investigate the Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia with or Without Astigmatism Dipanwita Samanta: samantad@upmc.edu -
- Glaucoma Studies
-
Condition Study Nickname Title of Study Study Coordinator Glaucoma, Ocular Hypertension COAST Clarifying the Optimal Application of SLT Therapy Trial Sashan Morris: morriss10@upmc.edu